Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Genentech has selected Biologics as limited distribution network partner for Tarceva that is approved for the treatment of non-small cell lung cancer and pancreatic cancer.
Subscribe to our email newsletter
The drug will only be available through Biologics, other selected specialty pharmacies and authorized distributors, but not at retail pharmacies.
Biologics chief executive officer and president Stuart Frantz said the company has the opportunity to continue delivering care to Tarceva patients.
"In addition to supporting our current patients, our team is also committed to helping providers and their patients across the country transition from retail to the specialty pharmacy network channel," Frantz added.
A clinically relevant team with expertise in complex therapy management at Biologics’ oncology pharmacy services group will ensure patient adherence and compliance.
A patient access services team conducts benefits investigation reviews and manages prior authorizations in addition to aiding in pursuing financial and copay assistance for the patients.